Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference22 articles.
1. Immunesurveillance of tumors;Swann;J. Clin. Invest.,2007
2. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma;Wahlin;Clin. Cancer Res.,2007
3. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome;Galon;Science,2006
4. Cancer immunotherapy: a treatment for the masses;Blattman;Science,2004
5. Use of tumour-responsive T cells as cancer treatment;Disis;Lancet,2009
Cited by 170 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25
2. Eficácia e Segurança do Blinatumomabe no Tratamento da Leucemia Linfoblástica Aguda: Revisão Sistemática da Literatura;Revista Brasileira de Cancerologia;2024-04-22
3. Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment;Cancers;2024-01-24
4. Exploring the Potential of Neoantigen-Targeted Immunotherapies in Rare Cancers;Handbook of Cancer and Immunology;2024
5. Anti-Tumour Necrosis Factor and New Paradigms for Therapies Using Antibodies;Molecular Biology of B Cells;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3